Where are you?
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Guernsey
  • Ireland
  • Italy
  • Jersey
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Portugal
  • Spain
  • Singapore
  • Sweden
  • Switzerland
  • United Kingdom
  • Rest of World
It looks like you’re in
Not your location?
And finally, please confirm the following details
I’m {role} in {country} and I agree to comply with the terms of the website.

Liontrust GF European Strategic Equity Fund

July 2021 review

Past performance is not a guide to future performance. Do remember that the value of an investment and the income generated from them can fall as well as rise.

The Fund’s A4 share class returned 2.0%* in euro terms in July. The Fund’s comparator benchmarks, the MSCI Europe Index and HFRX Equity Hedge EUR Index, returned 1.9% and 0.4% respectively.

 

Despite a mid-month wobble triggered by growing concerns over the spread of the Delta variant of Covid, European equity markets rallied to notch up a small gain for the month. Within this, IT (+5.6%), materials (+4.5%) and real estate (+4.5%) were the strongest areas but energy was the biggest laggard (-3.2%) by some margin.

 

The oil price was broadly flat on the month, finishing at US$76.3 a barrel, but there was some intra-month volatility on the global growth concerns and following an Opec meeting at which the cartel decided to restore output to pre-pandemic levels, but only by the end of 2022.

 

The pattern of equity market returns was not mirrored by bond markets – the mid-month dip in investor sentiment drove yields down but they did not rebound as equities recovered. Partial explanation for this pattern could be found in the key central bank policy announcements during the month: firstly, the European Central Bank said it could tolerate inflation temporarily higher that its new 2% target, opening the door for loose policy to be retained; and the US Federal Reserve commented that, although progress had been made towards its employment and inflation goals, it was still too early to tighten policy.

 

Turning to look at recent developments within our investment process, we’ve been observing a steady climb in one of our contrarian market indicators: corporate aggression. Rising aggression is a signal that company managers are becoming too optimistic about the outlook for growth and are backing these bold forecasts with substantial investments in operating assets. When combined with share valuations that are high on average, as they are now, this can be a warning sign.

 

As a result, we anticipate the opportunities for the Fund’s short book to be attractive over the next 12 months. In particular, there are pockets of the market where valuation dislocations are extreme, with some stocks scoring poorly against our cash flow criteria but still trading at exorbitant share price valuations. These are mostly found among stocks we classify under our ‘secondary score’ system as possessing Recovering Value or Growth characteristics.

 

In order to capture this opportunity, we have increased the size of our short position in the Fund to nearly 80%, up from around 50% at the turn of the year while the net market exposure has fallen from 66% to around 58%.

 

In July, returns from the short book were good, making a positive contribution to the Fund’s performance despite the rise in European markets. Highlights included share price falls triggered by disappointing trading updates from a Norwegian developer of learning games and a Norwegian krill harvester, while shares in a high-profile spaceflight operator dropped sharply after it announced a large fund-raising the day after a successful test-flight.

 

Within the long book, market research company Ipsos (+13%) was one of the better performing holdings. It reported interim revenue of just shy of 1bn – organic growth of 32% over 2020’s level and 14% higher than 2019. It has seen a very robust recovery in all regions, which has been matched by only a moderate 8% increase in payroll, resulting in a strong gearing effect on operating profit – up from €25m to €109m.

Having made gains in June on the back of an upbeat trading statement, shares in Belimo (+13%) made further headway after July’s release of interim results. It guided towards year-on-year net sales growth of about 10% in its trading update but went on to report a 17% local currency gain. The Swiss air-con actuator manufacturer commented that a faster-than-expected rebound in construction activity had driven a rapid return to above average sales growth.

 

Pump manufacturer Concentric (+12%) also rose. Its Q2 results showed a 45% constant currency year-on-year rebound in sales, diluted to 38% in reported terms by the strength of the Swedish krone. Demand for its engine and hydraulic products has improved as the year has gone on, with raw material supply now one of the main constraints on short-term growth. Reported sales rose 10% on Q1, and the company stated that orders received and expected to be fulfilled in Q3 are significantly higher again over the Q2 level.

 

Long book detractors included Lundin Energy (-11%), which slipped on the announcement that it would be taking Q2 income statement charge of US$119m of exploration and appraisal costs that did not yield a commercial discovery. Later in the month it released interim results that displayed strong operating trends: record Q2 revenue of US$1.3bn (following an average realised oil price of US$68 a barrel) and record free cash flow of US$949m.

 

Another faller was catering and support services group Elior (-8.3%), which with around half its revenues generated in France, may have been viewed as one of the more vulnerable to the spike in Delta Covid cases in the country and the imposition of any associated public health restrictions. Late in the month, Elior issued Q3 results showing a 39% year-on-year bounce in revenues to now sit at 74% of the pre-Covid comparable (March – June 2019).                                                                                                                    

Discrete years' performance** (%), to previous quarter-end:

 

Jun-21

Jun-20

Jun-19

Jun-18

Jun-17

Liontrust GF European Strategic Equity
A4 Acc EUR

36.9%

-15.5%

2.5%

3.0%

5.3%

MSCI Europe

27.9%

-5.5%

4.5%

2.8%

18.0%

HFRX Equity Hedge EUR

19.0%

-4.5%

-6.3%

3.5%

6.0%

 

*Source: Financial Express, as at 31.07.21, total return (income reinvested and net of fees). Non fund-related return data sourced from Bloomberg.

 

**Source: Financial Express, as at 30.06.21, total return (income reinvested and net of fees).

Understand common financial words and terms See our glossary
Key Risks 
 
Past performance is not a guide to future performance. The value of an investment and the income generated from it can fall as well as rise and is not guaranteed. You may get back less than you originally invested. The issue of units/shares in Liontrust Funds may be subject to an initial charge, which will have an impact on the realisable value of the investment, particularly in the short term. Investments should always be considered as long term.
 
Investment in Funds managed by the Cashflow Solution team involves foreign currencies and may be subject to fluctuations in value due to movements in exchange rates. Some of the Funds may invest in derivatives. The use of derivatives may create leverage or gearing. A relatively small movement in the value of a derivative's underlying investment may have a larger impact, positive or negative, on the value of a fund than if the underlying investment was held instead. Some of the funds may hold a concentrated portfolio of stocks. If the price of one of these stocks should move significantly, this may have a notable effect on the value of the respective portfolio.

 

Disclaimer
 
This is a marketing communication. Before making an investment, you should read the relevant Prospectus and the Key Investor Information Document (KIID), which provide full product details including investment charges and risks. These documents can be obtained, free of charge, from www.liontrust.co.uk or direct from Liontrust. Always research your own investments. If you are not a professional investor please consult a regulated financial adviser regarding the suitability of such an investment for you and your personal circumstances. 
 
This should not be construed as advice for investment in any product or security mentioned, an offer to buy or sell units/shares of Funds mentioned, or a solicitation to purchase securities in any company or investment product. Examples of stocks are provided for general information only to demonstrate our investment philosophy. The investment being promoted is for units in a fund, not directly in the underlying assets. It contains information and analysis that is believed to be accurate at the time of publication, but is subject to change without notice. Whilst care has been taken in compiling the content of this document, no representation or warranty, express or implied, is made by Liontrust as to its accuracy or completeness, including for external sources (which may have been used) which have not been verified. It should not be copied, forwarded, reproduced, divulged or otherwise distributed in any form whether by way of fax, email, oral or otherwise, in whole or in part without the express and prior written consent of Liontrust. Always research your own investments and if you are not a professional investor please consult a regulated financial adviser regarding the suitability of such an investment for you and your personal circumstances. 

Related commentaries

See all related

How to invest in Liontrust funds

Through a fund platform
Through a financial adviser
Direct with Liontrust